Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q2 2020 · 10-Q
Revenue$2.74M$2.74M+13.3% vs Q2 2019 Net Income-$675.34K-$675.34KN/M vs Q2 2019 EPS Diluted-$0.09-$0.09N/M vs Q2 2019 Operating Income-$672,981N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$169,507N/M Margins · derivedOperating margin-24.6%−15.2 pt vs Q2 2019
Net margin-24.6%−15.6 pt vs Q2 2019
ended Dec 31, 2019 · filed Feb 14, 2020 · 45 d after period end